Abstract:Objective: Maintenance treatment of schizophrenia with antipsychotic medications has become a standard for the prevention of psychotic relapse. However, little is known about the effectiveness of antipsychotic drugs for maintenance treatment in "real-world" populations with schizophrenia. We carried out a prospective study to assess the effectiveness of the most frequently prescribed antipsychotic drugs in the maintenance treatment of schizophrenia from 2 community settings. Methods: This study was conducted from October 2011 to December 2014. All participants were diagnosed with schizophrenia according to DSM-IV, were treated with an antipsychotic monotherapy, and were registered in a case management program with monthly monitoring for 24 months. The primary outcome measure, Positive and Negative Syndrome Scale (PANSS), and the Clinical Global Impressions-Severity of Illness (CGI-S) and -Improvement (CGI-I) scales were used to evaluate symptom severity and treatment response. The Personal and Social Performance scale (PSP) was used to evaluate the patients' social functioning. The Medication Adherence Rating Scale (MARS) was used to assess medication adherence behavior. On the basis of antipsychotic used at baseline, patients were clustered into 7 groups: aripiprazole (n = 21), clozapine (n = 84), chlorpromazine (n = 61), olanzapine (n = 34), perphenazine (n = 21), quetiapine (n = 27), and risperidone (n = 99). Results: Of the 347 patients enrolled in the study, 312 completed the 24-month follow-up. There were no significant differences among the treatment groups in the PANSS total and subscale scores or the CGI-S and CGI-I scores over 24 months (all P values >.05). There were also no significant differences in interactions between PSP scores and antipsychotic drugs (P =.17). The remission rates increased as the followtime lapsed in all groups, but no significant difference was observed in remission rates at each time point among the 7 groups (P values >.05). At the endpoint, MARS total scores were over 6, but did not significantly differ among the studied drugs (P =.24). Conclusions: These findings suggest that antipsychotic drugs can achieve equivalent effectiveness in maintenance treatment of firstepisode schizophrenia through a well-organized case management program and family participation. (C) Copyright 2016 Physicians Postgraduate Press, Inc.

[Effect of Antipsychotic Drugs on Life Quality of Schizophrenic Patients: One Year Follow-Up Study].

Effects of Antipsychotic Medications on Quality of Life and Psychosocial Functioning in Patients with Early-Stage Schizophrenia: 1-Year Follow-Up Naturalistic Study

Maintenance treatment effectiveness of seven antipsychotic drugs in schizophrenic patients: a 1-year follow-up study

Metabolic Effects Of 7 Antipsychotics On Patients With Schizophrenia: A Short-Term, Randomized, Open-Label, Multicenter, Pharmacologic Trial

Socio-Demographic and Clinical Determinants of Quality of Life in Chinese Patients with Schizophrenia: A Prospective Study

Effect of Antipsychotic Medication Alone Vs Combined with Psychosocial Intervention on Outcomes of Early-Stage Schizophrenia: A Randomized, 1-Year Study.

Antipsychotic Medications in Major Depression and the Association with Treatment Satisfaction and Quality of Life: Findings of Three National Surveys on Use of Psychotropics in China Between 2002 and 2012

Neurocognitive Effects of First- and Second-Generation Antipsychotic Drugs in Early-Stage Schizophrenia: A Naturalistic 12-Month Follow-Up Study

Effectiveness of Antipsychotic Drugs for 24-Month Maintenance Treatment in First-Episode Schizophrenia: Evidence From a Community-Based "Real-World" Study.

P03-367 - Neurocognitive effects of atypical and conventional antipsychotic drugs in early-stage schizophrenia: a naturalistic 12-month follow-up study

Comparative Study on Quality of Life of Schizophrenics treated with Risperidone or Clozapine

Quantitative efficacy of three antipsychotic drugs for schizophrenia based on a real-world study in China

Effectiveness of Antipsychotic Drugs for 24-Month Maintenance Treatment in First-Episode Schizophrenia

Long-Term Antipsychotic Effectiveness and Comparison of the Efficacy of Monotherapy and Polypharmacy in Schizophrenia: A 3-Years Follow-Up "real World" Study in China.

One year follow-up study on olanzapine in the treatment of patients with first-episode schizophrenia

Randomized controlled 16-week trial of the effect of quetiapine on the quality of life and cognitive functioning of patients in acute episodes of schizophrenia

One year follow-up study of olanzapine and risperidone in the treatment of patients with first-episode schizophrenia

Antipsychotic polypharmacy in schizophrenia patients in China and its association with treatment satisfaction and quality of life: findings of the third national survey on use of psychotropic medications in China.

Neurocognitive Effects of Atypical and Conventional Antipsychotic Drugs in Early-Stage Schizophrenia: A Naturalistic 12-Month Follow-Up Study

Antipsychotic Alone Venus Combined with Psychosocial Intervention on One-Year Outcome in Non-Chronic Schizophrenia

Long‐term efficacy of antipsychotic drugs in initially acutely ill adults with schizophrenia: systematic review and network meta‐analysis